Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Potter

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Biochimica Et Biophysica Acta|September 3, 2008
Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophagesJ Allen Crow, Brandy L Middleton, Abdolsamad Borazjani, et al.
Molecular Pharmacology|July 19, 2003
Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistanceMonika Wierdl, Amelia Wall, Christopher L Morton, et al.
The AAPS Journal|February 20, 2009
Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants II: role of plasma esterases in drug releaseXiuling Lu, Melissa D Howard, Dominique R Talbert, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 21, 2006
Species differences in the in vitro metabolism of deltamethrin and esfenvalerate: differential oxidative and hydrolytic metabolism by humans and ratsStephen J Godin, Edward J Scollon, Michael F Hughes, et al.
Journal of Molecular Modeling|December 1, 2011
Global and local molecular dynamics of a bacterial carboxylesterase provide insight into its catalytic mechanismXiaozhen Yu, Sara C Sigler, Delwar Hossain, et al.
Nature Structural Biology|April 23, 2002
Structural insights into CPT-11 activation by mammalian carboxylesterasesSompop Bencharit, Christopher L Morton, Escher L Howard-Williams, et al.
Biochimica Et Biophysica Acta|November 4, 2010
Mouse serum paraoxonase-1 lactonase activity is specific for medium-chain length fatty acid lactonesPhilip W Connelly, Clive M Picardo, Philip M Potter, et al.
Biotechnology Progress|April 22, 2011
Immobilization of active human carboxylesterase 1 in biomimetic silica nanoparticlesJonathan S Edwards, Amar Kumbhar, Adam Roberts, et al.
Chemistry & Biology|May 3, 2003
Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibitionSompop Bencharit, Christopher L Morton, Janice L Hyatt, et al.
Journal of Medicinal Chemistry|June 19, 2009
Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicityLatorya D Hicks, Janice L Hyatt, Shana Stoddard, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Biochimica Et Biophysica Acta|September 3, 2008
Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophagesJ Allen Crow, Brandy L Middleton, Abdolsamad Borazjani, et al.
Molecular Pharmacology|July 19, 2003
Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistanceMonika Wierdl, Amelia Wall, Christopher L Morton, et al.
The AAPS Journal|February 20, 2009
Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants II: role of plasma esterases in drug releaseXiuling Lu, Melissa D Howard, Dominique R Talbert, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 21, 2006
Species differences in the in vitro metabolism of deltamethrin and esfenvalerate: differential oxidative and hydrolytic metabolism by humans and ratsStephen J Godin, Edward J Scollon, Michael F Hughes, et al.
Journal of Molecular Modeling|December 1, 2011
Global and local molecular dynamics of a bacterial carboxylesterase provide insight into its catalytic mechanismXiaozhen Yu, Sara C Sigler, Delwar Hossain, et al.
Nature Structural Biology|April 23, 2002
Structural insights into CPT-11 activation by mammalian carboxylesterasesSompop Bencharit, Christopher L Morton, Escher L Howard-Williams, et al.
Biochimica Et Biophysica Acta|November 4, 2010
Mouse serum paraoxonase-1 lactonase activity is specific for medium-chain length fatty acid lactonesPhilip W Connelly, Clive M Picardo, Philip M Potter, et al.
Biotechnology Progress|April 22, 2011
Immobilization of active human carboxylesterase 1 in biomimetic silica nanoparticlesJonathan S Edwards, Amar Kumbhar, Adam Roberts, et al.
Chemistry & Biology|May 3, 2003
Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibitionSompop Bencharit, Christopher L Morton, Janice L Hyatt, et al.
Journal of Medicinal Chemistry|June 19, 2009
Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicityLatorya D Hicks, Janice L Hyatt, Shana Stoddard, et al.
Pageof 9